Skip to main content

Table 1 Type of products receiving FP7 grants

From: EU FP7 research funding for an orphan drug (Orfadin®) and vaccine (Hep C) development: a success and a failure?

Type of product

Number of FP7 product-related awards

Total EC funding across awards

Pharmaceutical product

66

€ 374,566,636.44

Medicine product/device

26

€ 132,960,884.58

Vaccine

18

€ 103,555,184.34

Gene therapy/regenerative therapy/cell therapy

10

€ 75,788,694.05

Total

120

€ 686,871,399.41